With the recent surge in the number infants diagnosed with Neonatal Abstinence Syndrome (NAS), this quality improvement project was completed to measure the number of deviations from NAS pharmacological management guidelines. The goal was to inform practice and to provide an opportunity for improvement through education or guideline modification.

Items submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Henderson Repository, unless otherwise noted.

<p><span>With the recent surge in the number infants diagnosed with Neonatal Abstinence Syndrome (NAS), this quality improvement project was completed to measure the number of deviations from NAS pharmacological management guidelines. The goal was to inform practice and to provide an opportunity for improvement through education or guideline modification.</span></p>

Items submitted to a conference/event were evaluated/peer-reviewed at the time of abstract submission to the event. No other peer-review was provided prior to submission to the Henderson Repository, unless otherwise noted.

-

All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.